title: A case of pyoderma gangrenosum possibly associated with sunitinib treatment.
authors.forename: Yuri
authors.initials: Y
authors.lastname: Ueharaguchi
authors.forename: Kenji
authors.initials: K
authors.lastname: Kabashima
authors.forename: Makiko
authors.initials: M
authors.lastname: Sasahashi
authors.forename: Ayumu
authors.initials: A
authors.lastname: Matsuda
authors.forename: Kunihiko
authors.initials: K
authors.lastname: Matubara
authors.forename: Miho
authors.initials: M
authors.lastname: Matsui
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D017511:Pyoderma Gangrenosum / Q000139:chemically induced* / Q000188:drug therapy; D011758:Pyrroles / Q000009:adverse effects*; D000077210:Sunitinib
chemical_list: D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib; D011241:Prednisone